Based in the San Francisco Bay Area, IDbyDNA is developing technologies to enable universal microorganism detection. IDbyDNA's mission is to help doctors and scientists to detect any pathogen in any sample, thereby removing barriers for the adoption of metagenomics in clinical settings, ultimately leading to faster public health responses during infectious disease outbreaks.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/09/16 | $9,000,000 | Series A |
Artis Ventures ARUP Laboratories | undisclosed |
